TABLE 3.

Multivariate Logistic Regression Analysis for Heart Failure Within 12 Months After LT, Stroke Within 12 Months After LT, and Renal Failure at 12 Months After LT (excluding SLKT)

	Univariate Analysis		Multivariate Analysis
	OR	95% CI	OR	95% CI
Heart failure within 12 months after LT
Age at transplant (per year increase)	1.06	0.96–1.17	1.06	0.95–1.18
Sex, male (reference: female)	0.95	0.56–1.59	0.79	0.45–1.38
Laboratory MELD at transplant (per unit increase)	1.02	1.00–1.04	1.03	1.01–1.06
History of CABG	2.95	1.09–7.98	2.35	0.77–7.10
History of CAD with PCI	2.74	1.33–5.65	2.59	1.16–5.79
History of atrial fibrillation	3.34	1.73–6.46	3.24	1.58–6.67
Diastolic dysfunction on transthoracic echocardiogram (reference: absent)
Present	0.66	0.35–1.24	0.64	0.32–1.28
Unknown or unable to measure	0.79	0.43–1.47	0.82	0.43–1.56
NASH	1.19	0.66–2.17	0.92	0.48–1.76
Stroke within 12 months after LT
Age at transplant (per year increase)	1.03	0.93–1.15	1.03	0.92–1.15
Sex, male (reference: female)	0.54	0.31–0.93	0.53	0.30–0.93
Laboratory MELD at transplant (per unit increase)	1.00	0.97–1.02	0.99	0.96–1.02
History of any CAD	1.83	1.04–3.22	1.65	0.90–3.03
History of atrial fibrillation	2.50	1.17–5.32	2.29	1.05–5.03
Pre-LT diabetes	1.31	0.76–2.25	1.08	0.59–2.00
Pre-LT hypertension	1.01	0.59–1.74	0.93	0.53–1.65
NASH	1.61	0.89–2.95	1.36	0.70–2.67
Renal failure at 12 months after LT
Age at transplant (per year increase)	1.04	0.96–1.13	1.06	0.97–1.17
Sex, male (reference: female)	0.82	0.54–1.25	0.80	0.51–1.27
Laboratory MELD at transplant (per unit increase)	1.07	1.05–1.09	1.05	1.02–1.07
Pre-LT moderate or severe renal disease	4.37	2.86–6.70	2.82	1.65–4.82
Pre-LT ascites	2.70	1.64–4.46	1.18	0.65–2.15
Pre-LT diabetes	1.14	0.75–1.73	1.17	0.72–1.91
Pre-LT hypertension	0.95	0.63–1.44	0.86	0.54–1.37
NASH	1.13	0.69–1.84	0.83	0.47–1.48

NOTE: Bold value indicates statistical significance.

Variables were selected based on known risk factors and/or significance in the univariate analysis.